U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. Improving the Diagnosis and Treatment of Women with Myocardial Ischemia and Non-obstructive Coronary Arteries - 05/09/2024
  1. Advancing Regulatory Science

Webcast | Virtual

Event Title
Improving the Diagnosis and Treatment of Women with Myocardial Ischemia and Non-obstructive Coronary Arteries
May 9, 2024

Date:
May 9, 2024

Yale University/Mayo Clinic CERSI

Thursday, May 9th, 2024

Presented By

Samit Shah, MD, PhD

Samit Shah, MD, PhD
Assistant Professor of Medicine
Yale School of Medicine

About the Presentation

Ischemic heart disease is a leading cause of morbidity and mortality in women. In contrast to men, where atherosclerotic coronary artery disease (CAD) is the most common form of heart disease, two thirds of women suffer from myocardial ischemia with non-obstructive coronary arteries (INOCA). Women with INOCA have unique symptoms and are more likely to have functional limitation and repeat presentations for cardiovascular evaluation. While there has been increasing recognition of INOCA there is no specific functional status measure, limiting our ability to evaluate the course of illness or effectiveness of therapies. In this presentation we reviewed the causes of ischemic heart disease in women, challenges with current symptom assessment measures, and proposed a new path for better diagnosis and treatment of heart disease in women.

About the Presenter

Samit Shah is an Interventional Cardiologist who specializes in the invasive evaluation of coronary artery disease, coronary physiology, and complex coronary interventions. He was an undergraduate at the Pennsylvania State University and went to medical school at the University of Illinois College of Medicine, where he graduated with a medical doctorate as well as PhD in Neuroscience. He subsequently completed his internship and residency in Internal Medicine at Yale New Haven Hospital, followed by clinical fellowships in Cardiovascular Medicine, Peripheral Vascular Interventions, and Interventional Cardiology. Dr. Shah has received numerous honors for patient care and education, including the Dr. Lynda Rosenfeld Cardiology Fellowship Teacher of the Year Award, Wendy U. and Thomas C. Naratil Pioneer Award, Veterans Administration I CARE Award, and Yale Internal Medicine Excellence in Outpatient Care Award. In 2023, he was recognized by the Society of Cardiovascular Angiography and Interventions (SCAI) as a "30 in their 30's" award recipient for professional excellence in interventional cardiology. His scholarly work has focused on the outcomes of cardiovascular interventions and the invasive assessment of coronary physiology. He is the national co-principal investigator of the DISCOVER INOCA multi-center registry, and has active research projects at Yale regarding the diagnostic yield of invasive coronary physiology testing, ischemic heart disease in women, and the vascular effects of psychological stress.

Recording

Play recording (57 mins)

For Questions:

Please contact Ruize Li at Ruize.Li@fda.hhs.gov.

Back to Top